NFA
AGIO icon

Nationwide Fund Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Nationwide Fund Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,344
Closed -$423K – 57
2017
Q3 		$423K Buy
6,344
+1,740
+38% +$105K ﹤0.01% 2262
2017
Q2 		$237K Sell
4,604
-5,500
-54% -$281K ﹤0.01% 2558
2017
Q1 		$590K Buy
10,104
+500
+5% +$24K ﹤0.01% 2067
2016
Q4 		$401K Hold
9,604
– – ﹤0.01% 2294
2016
Q3 		$507K Buy
9,604
+5,000
+109% +$218K ﹤0.01% 2172
2016
Q2 		$193K Hold
4,604
– – ﹤0.01% 2633
2016
Q1 		$187K Hold
4,604
– – ﹤0.01% 2562
2015
Q4 		$299K Hold
4,604
– – ﹤0.01% 2354
2015
Q3 		$325K Hold
4,604
– – ﹤0.01% 2338
2015
Q2 		$512K Sell
4,604
-12,537
-73% -$1.35M ﹤0.01% 2232
2015
Q1 		$1.62M Sell
17,141
-385
-2% -$43.1K 0.01% 1615
2014
Q4 		$1.96M Sell
17,526
-4,839
-22% -$432K 0.01% 1423
2014
Q3 		$1.37M Buy
22,365
+46
+0.2% +$1.98K 0.01% 1658
2014
Q2 		$1.02M Buy
22,319
+3,123
+16% +$127K ﹤0.01% 1847
2014
Q1 		$752K Sell
19,196
-2,404
-11% -$80.4K ﹤0.01% 1873
2013
Q4 		$517K Buy
21,600
+5,815
+37% +$133K ﹤0.01% 2225
2013
Q3 		$441K Buy
+15,785
New +$436K ﹤0.01% 2286

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Nationwide Fund Advisors's AGIO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Agios Pharmaceuticals (AGIO) in Q4 2017, closing a stake of 6,344 shares — an estimated $423K sold.

Nationwide Fund Advisors first reported a position in AGIO in Q3 2013 and held it in 17 quarters. The position peaked at $1.96M in Q4 2014. 178 funds tracked by Wall St. Rank hold AGIO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Agios Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 6,344 Agios Pharmaceuticals shares in Q4 2017, an estimated $423K.
  • Nationwide Fund Advisors first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Agios Pharmaceuticals position peaked at $1.96M in Q4 2014.
  • 178 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.